Your browser does not support iframes.
Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Incyte Genomics, Inc.
(NQ:
INCY
)
22.26
USD
-0.89 (-3.84%)
Official Closing Price
/ Updated:
5:20 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Incyte Genomics, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Incyte (INCY) Posts Q4 EPS of $0.14, Sales Easily Beat Views
February 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8095154 for the full story.
Read More
from
StreetInsider.com News Articles
Trading Radar for 02/14: General Motors (GM), CBS (CBS), DirecTV (DTV), Pepsi (PEP), Orbitz (OWW) Report
February 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8093311 for the full story.
Read More
from
StreetInsider.com News Articles
UK cost agency says 'no' to Novartis blood cancer drug Jakavi
February 12, 2013
LONDON, Feb 13 (Reuters) - A new drug from Novartis for myelofibrosis, a rare blood cancer, is not worth using on the state health service, Britain's healthcare cost watchdog said on Wednesday.
Read More
category
companyNews
from
Reuters: Company News
Incyte Crosses Above its 10-day MA (INCY)
February 06, 2013
from
Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes 01/23: (ALU) (WLT) (STR) Upgraded; (F) (SNV) (DD) Downgraded
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8025712 for the full story.
Read More
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 01/23: (MAPP) (CREE) (GOOG) Higher; (COH) (BNNY) (MCP) Lower (more...)
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8025455 for the full story.
Read More
from
StreetInsider.com News Articles
Morgan Stanley Downgrades Incyte (INCY) to Underweight
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8024585 for the full story.
Read More
from
StreetInsider.com News Articles
4 Research Firms Generating Value Through New Drug Technology
January 14, 2013
category
Pharmaceuticals
from
Trefis
Lazard Capital Upgrades Incyte (INCY) to Buy
January 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8004472 for the full story.
Read More
from
StreetInsider.com News Articles
16.9% Return Seen to Date on SmarTrend Incyte Call (INCY)
December 27, 2012
from
Comtex SmarTrend® News Briefs
Incyte Down 16.0% Since SmarTrend Downtrend Call (INCY)
December 20, 2012
from
Comtex SmarTrend® News Briefs
Downtrend Call Working As Incyte Stock Falls 12.3% (INCY)
December 13, 2012
from
Comtex SmarTrend® News Briefs
Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in the Markets
December 12, 2012
Toward the end of trading Wednesday, the Dow traded down 0.13 percent to 13,231.78 while the NASDAQ fell 0.38 percent to 3,010.22. The S&P also fell, decreasing 0.04 percent to 1,427.24. Top Headline...
Read More
category
Earnings
,
US1598641074
,
Benzinga
, and 25 more.
from
Latest Articles from Benzinga.com
Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise
December 12, 2012
Mid-way through trading Wednesday, the Dow traded up 0.49 percent to 13,313.93 while the NASDAQ rose 0.26 percent to 3,030.22. The S&P also rose, increasing 0.62 percent to 1,436.63. Top Headline In...
Read More
category
Earnings
,
US1598641074
,
Benzinga
, and 25 more.
from
Latest Articles from Benzinga.com
Gilead Makes Another Bet on Cancer, Incyte Shares Fall
December 12, 2012
MINYANVILLE ORIGINAL In the biotech world a half-billion-dollar deal is still a lot of money. For Gilead Sciences (NASDAQ:GILD) a $58 billion market-cap company the takeover of YM BioSciences...
Read More
from
Minyanville Headlines
Unusual 11 Mid-Day Movers 12/12: (YMI) (JKS) (LDK) Higher; (CENT) (ACUR) (CIE) Lower
December 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7943231 for the full story.
Read More
from
StreetInsider.com News Articles
Incyte Trading Lower on Heavy Volume, Inline With Overall Trend (INCY)
December 12, 2012
from
Comtex SmarTrend® News Briefs
Mid-Morning Market Update: Markets Flat in Anticipation of FOMC Statement
December 12, 2012
Following the market opening Wednesday, the Dow traded up 0.16 percent to 13,270.18 while the NASDAQ rose 0.10 percent to 3,025.24. The S&P also rose, increasing 0.22 percent to 1,431.02. Top Headline...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 25 more.
from
Latest Articles from Benzinga.com
Incyte Bearish Moving Average Crossover Alert (INCY)
December 12, 2012
from
Comtex SmarTrend® News Briefs
Markets Edge Up, Fed Stimulus News Offset By Fiscal Cliff Uncertainties
December 12, 2012
Optimism about the Federal Reserve's move to increase liquidity was tempered by negativity surrounding the daily political tug-of-war to avert the fiscal cliff. The Dow rose 23 points to 13,272 while...
Read More
category
Market News
from
MarketMinute.com Market Updates
Incyte Genomics (INCY) Falls on Gilead/YM BioSciences Deal
December 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7942377 for the full story.
Read More
from
StreetInsider.com News Articles
3 Biotechnology Stocks to Buy Now
December 12, 2012
Read More
category
NASDAQ:SSRX
,
Stocks to Buy
,
NASDAQ:INCY
, and 1 more.
from
InvestorPlace - Latest Headlines
Eli Lilly and Other Healthcare Stocks Making Big Moves on December 12, 2012
December 12, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.2% and the Dow is up 0.2% after the morning's trading. The healthcare sector is the category of stocks relating to medical and healt...
Read More
from
Investopedia Advisor Commentary
Incyte Corporation Larger Than S&P 500 Component E*trade Financial Corporation
December 10, 2012
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Incyte Corporation (INCY) was identified as having a larger market cap than the smaller end of the S&P 500,...
Read More
category
Stocks
from
Market News Video
Incyte Bearish Moving Average Crossover Alert (INCY)
November 28, 2012
from
Comtex SmarTrend® News Briefs
Post Earnings Update: Incyte Has Sunk 3.7% Lower in Past 2 Weeks (INCY)
November 19, 2012
from
Comtex SmarTrend® News Briefs
Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis
November 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7877817 for the full story.
Read More
from
StreetInsider.com News Articles
4 Biotechnology Stocks to Buy Now
November 14, 2012
Read More
category
NASDAQ:SSRX
,
Stocks to Buy
,
NASDAQ:INCY
, and 2 more.
from
InvestorPlace - Latest Headlines
Incyte Shares Down 13.0% Since SmarTrend's Sell Call (INCY)
November 09, 2012
from
Comtex SmarTrend® News Briefs
Guggenheim Starts Incyte (INCY) at Buy
November 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7861765 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.